Benefits from standalone durvalumab treatment in an elderly patient with advanced prostatic sarcoma: a case report

por Wang, Lili, Wang, Lei, Hou, Dingkun, Dong, Shiqiang, Wang, Aixiang, Wang, Haitao
Publicado 2021

Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of MITD1

por Dong, Shiqiang, Hou, Dingkun, Peng, Yun, Chen, Xiaoxu, Li, Hongzheng, Wang, Haitao
Publicado 2022

Key sunitinib‐related biomarkers for renal cell carcinoma

por Peng, Yun, Dong, Shiqiang, Song, Yuxuan, Hou, Dingkun, Wang, Lili, Li, Bowen, Wang, Haitao
Publicado 2021

A prognostic nomogram based on competing endogenous RNA network for clear‐cell renal cell carcinoma

por Peng, Yun, Wu, Shangrong, Xu, Zihan, Hou, Dingkun, Li, Nan, Zhang, Zheyu, Wang, Lili, Wang, Haitao
Publicado 2021

A comprehensive characterization of the transcriptome in enzalutamide resistance prostate cancer

por Wang, Lili, Peng, Yun, Dong, Shiqiang, Hou, Dingkun, Li, Nan, Li, Hongzheng, Li, Tianyang, Zhang, Zheyu, Wang, Haitao
Publicado 2021